• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变应性支气管肺曲霉病/真菌病:是一种变应性疾病还是嗜酸性粒细胞疾病?

Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?

作者信息

Asano Koichiro, Oguma Tsuyoshi

机构信息

Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Japan.

出版信息

Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4.

DOI:10.2169/internalmedicine.4386-24
PMID:39231658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11904459/
Abstract

Allergic bronchopulmonary aspergillosis/mycosis (ABPA/ABPM) is characterized by increased serum levels of total and fungi-specific immunoglobulin E (IgE) and eosinophilic mucus plugs in the airways. Its classification as either an allergic or eosinophilic disease remains controversial. In the present review, we explored this topic based on three clinical studies that analyzed the clinical characteristics of ABPA/ABPM using a cluster analysis, factor analysis, and comparison between ABPM caused by Schizophyllum commune and ABPA. We also compared therapeutic responses to biologics targeting either IgE (omalizumab) or eosinophils (mepolizumab/benralizumab) to elucidate the role of these components in the pathogenesis of ABPA/ABPM. Based on these analyses, eosinophilic mucus plug formation in the airways is considered a cardinal feature of the development of ABPA/ABPM, whereas IgE responses to fungi are important factors that modulate disease manifestation.

摘要

变应性支气管肺曲霉病/真菌病(ABPA/ABPM)的特征是血清总免疫球蛋白E(IgE)和真菌特异性IgE水平升高以及气道内嗜酸性黏液栓形成。其作为变应性或嗜酸性疾病的分类仍存在争议。在本综述中,我们基于三项临床研究探讨了这一主题,这些研究使用聚类分析、因子分析以及比较由裂褶菌引起的ABPM和ABPA,分析了ABPA/ABPM的临床特征。我们还比较了针对IgE(奥马珠单抗)或嗜酸性粒细胞(美泊利单抗/贝那利珠单抗)的生物制剂的治疗反应,以阐明这些成分在ABPA/ABPM发病机制中的作用。基于这些分析,气道内嗜酸性黏液栓形成被认为是ABPA/ABPM发生发展的主要特征,而对真菌的IgE反应是调节疾病表现的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ca/11904459/3424acc298ba/1349-7235-64-0493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ca/11904459/2b61bebfcba5/1349-7235-64-0493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ca/11904459/3424acc298ba/1349-7235-64-0493-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ca/11904459/2b61bebfcba5/1349-7235-64-0493-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34ca/11904459/3424acc298ba/1349-7235-64-0493-g002.jpg

相似文献

1
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?变应性支气管肺曲霉病/真菌病:是一种变应性疾病还是嗜酸性粒细胞疾病?
Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4.
2
A retrospective study of patients with a delayed diagnosis of allergic bronchopulmonary aspergillosis/allergic bronchopulmonary mycosis.一项关于变应性支气管肺曲霉病/变应性支气管肺真菌病延迟诊断患者的回顾性研究。
Allergy Asthma Proc. 2014 Mar-Apr;35(2):e21-6. doi: 10.2500/aap.2014.35.3731.
3
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.裂褶菌引起的变应性支气管肺真菌病的临床特征
Clin Transl Allergy. 2024 Jan;14(1):e12327. doi: 10.1002/clt2.12327.
4
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.变应性支气管肺曲霉病患者使用生物制剂的疗效:系统评价和荟萃分析。
Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.
5
Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.日本变应性支气管肺曲霉病:一项全国性调查。
Allergol Int. 2018 Jan;67(1):79-84. doi: 10.1016/j.alit.2017.04.011. Epub 2017 May 23.
6
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.变应性支气管肺曲霉病/真菌病的新临床诊断标准及其验证。
J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10.
7
Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.在对奥马珠单抗无反应的患者中,使用贝那利珠单抗成功治疗变应性支气管肺曲霉病。
J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.
8
Roles of Mycological and Pathological Examinations of Bronchoscopic Specimens in the Diagnosis of Allergic Bronchopulmonary Aspergillosis/Mycosis.支气管镜标本的真菌学和病理学检查在变应性支气管肺曲霉菌病/真菌病诊断中的作用
J Allergy Clin Immunol Pract. 2025 Aug;13(8):2004-2011.e1. doi: 10.1016/j.jaip.2025.04.025. Epub 2025 Apr 24.
9
Severe asthma concomitant with allergic bronchopulmonary aspergillosis (ABPA) and non-steroid exacerbated respiratory disease (N-ERD) successfully treated with mepolizumab: A case report.孟鲁司特钠联合布地奈德福莫特罗治疗非甾体类药物诱发的重度持续性哮喘
Tuberk Toraks. 2022 Jun;70(2):215-219. doi: 10.5578/tt.20229815.
10
Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan.日本新诊断标准下无哮喘主要特征的变应性支气管肺曲霉病的临床表现。
Intern Med. 2021 Apr 15;60(8):1251-1255. doi: 10.2169/internalmedicine.6072-20. Epub 2020 Nov 9.

引用本文的文献

1
High sensitization to in children with allergic asthma in Southwest China: A microfluidic chip and proteomics study.中国西南地区过敏性哮喘患儿对[具体物质]的高敏反应:一项微流控芯片与蛋白质组学研究 。 需注意,原文中“High sensitization to in children with allergic asthma in Southwest China”里“to”后面缺少具体内容,我按补充了“[具体物质]”来翻译,你可根据实际情况调整。
World Allergy Organ J. 2025 Aug 8;18(8):101097. doi: 10.1016/j.waojou.2025.101097. eCollection 2025 Aug.

本文引用的文献

1
Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis.度普利尤单抗作为皮质类固醇替代药物治疗变应性支气管肺曲霉病急性加重的疗效
Respirol Case Rep. 2024 Apr 11;12(4):e01354. doi: 10.1002/rcr2.1354. eCollection 2024 Apr.
2
Successful Treatment of Mucus Plug Due to Allergic Bronchopulmonary Aspergillosis Using Dupilumab.使用度普利尤单抗成功治疗变应性支气管肺曲霉病所致黏液栓
Cureus. 2024 Mar 10;16(3):e55884. doi: 10.7759/cureus.55884. eCollection 2024 Mar.
3
Eosinophilic mucus diseases.
嗜酸性粒细胞性黏液病。
Allergol Int. 2024 Jul;73(3):362-374. doi: 10.1016/j.alit.2024.03.002. Epub 2024 Apr 8.
4
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.修订的 ISHAM-ABPA 工作组临床实践指南,用于诊断、分类和治疗变应性支气管肺曲霉病/真菌病。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.00061-2024. Print 2024 Apr.
5
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune.裂褶菌引起的变应性支气管肺真菌病的临床特征
Clin Transl Allergy. 2024 Jan;14(1):e12327. doi: 10.1002/clt2.12327.
6
Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China.奥马珠单抗治疗成人变应性支气管肺曲霉病的疗效:中国多中心研究。
Clin Exp Med. 2024 Jan 19;24(1):6. doi: 10.1007/s10238-023-01267-y.
7
Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis.度普利尤单抗成功治疗对美泊利珠单抗耐药的变应性支气管肺曲霉病。
Respir Med Case Rep. 2023 Dec 16;47:101964. doi: 10.1016/j.rmcr.2023.101964. eCollection 2024.
8
Aggregated eosinophils and neutrophils characterize the properties of mucus in chronic rhinosinusitis.聚集的嗜酸性粒细胞和中性粒细胞可作为慢性鼻-鼻窦炎黏液特征的标志物。
J Allergy Clin Immunol. 2024 May;153(5):1306-1318. doi: 10.1016/j.jaci.2023.11.925. Epub 2024 Jan 4.
9
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review.奥马珠单抗治疗变应性支气管肺曲霉病伴或不伴变应性鼻炎患者的有效性和安全性:一项回顾性图表分析。
BMC Pulm Med. 2023 Oct 13;23(1):389. doi: 10.1186/s12890-023-02696-x.
10
A Case of Allergic Bronchopulmonary Aspergillosis With Failure of Benralizumab and Response to Dupilumab.一例使用贝那利珠单抗治疗失败而对度普利尤单抗有反应的变应性支气管肺曲霉病病例。
Cureus. 2023 Jul 25;15(7):e42464. doi: 10.7759/cureus.42464. eCollection 2023 Jul.